Home›Research›Compare›LL-37 vs Teduglutide
Peptide ComparisonLL-37 vs Teduglutide
Both are Tissue Repair peptides.
Teduglutide
Gattex
Half-life: ~2 hours
No providers listed yet
Teduglutide is FDA-approved, while LL-37 is nomination withdrawn — the clearest structural difference between them.
LL-37
Evidence
Half-life
~30 minutes
Teduglutide
Evidence
Half-life
~2 hours
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Teduglutide |
| Further along in FDA review | Teduglutide |
| Less frequent dosing (longer half-life) | Teduglutide |
| More provider options (38 vs 0) | LL-37 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
LL-37
Teduglutide
LL-37
Immunomodulatory effects of synthetic antimicrobial peptides on LPS-induced inflammatory responses in THP-1 m…
The Role of Vitamin D in Modulating the Innate Immune Response in Children with Vesicoureteral Reflux.
Antimicrobial peptoids pass rapidly through bacterial membranes and flocculate ribosomes and DNA: A single-ce…
Antimicrobial peptoids pass rapidly through bacterial membranes and flocculate ribosomes and DNA: A single-ce…
+15 more
Teduglutide
From childhood to adulthood in chronic intestinal failure: A nationwide study.
A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in…
PERCC1-associated enteropathy: Diagnostic challenges and enteral autonomy achieved with teduglutide.
Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?
+5 more
About LL-37
Human cathelicidin antimicrobial peptide; disrupts bacterial membranes and modulates innate immune response via TLR signaling
About Teduglutide
GLP-2 receptor agonist; stimulates intestinal epithelial proliferation and reduces apoptosis; increases intestinal blood flow and inhibits gastric motility
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
LL-37
No established clinical contraindications
Teduglutide
No established clinical contraindications
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
LL-37
Teduglutide
Not enough vendor pricing yet.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Tissue Repair Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). LL-37 vs Teduglutide — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/ll-37/teduglutide